HAUPPAUGE, N.Y., Jan. 21, 2010 (GLOBE NEWSWIRE) -- Patient Access Solutions, Inc. (Pink Sheets:PASO), an emerging provider of healthcare/financial processing technologies that provide the healthcare industry a graceful migration to Electronic Medical Records (EMR), today announced the signing of an exclusive contract with Catrel AB of Sweden where Patient Access Solutions will become the exclusive U.S. Mobipen™ partner targeting the $55 Billion U.S. home healthcare market.
Mobipen is a digital pen application, based on Anoto technology, for the home healthcare industry that takes handwritten documents and turns them into usable data that can be stored in computer systems. The technology allows for faster and more efficient documentation of patient care, improved document retention, better flow of information from the point of patient care into both electronic medical record and traditional healthcare oriented information technology environments.
"The combination of our D-PAS digital pen technology and the state of the art Mobipen system, both based on Anoto Technology, hold the potential to revolutionize how information is gathered and processed within the home healthcare environment. The traditional method of hand written forms, which must then later be entered into computerized systems, is prone to errors, inflexible and expensive," commented Bruce Weitzberg CEO of Patient Access Solutions, Inc. "Through this partnership home healthcare workers and organizations will have access to a much more sophisticated and far less expensive information gathering and document management system. With this technology the home healthcare worker uses a light weight digital 'pen' that operates virtually identical to an ordinary ink-based pen. A sophisticated camera inside the pen records the pen strokes into the integrated memory, which can store up to 200 pages of information. This information is then easily downloaded into virtually any computer system, including industry standards-based EMR systems. Many home healthcare-related organizations that are currently utilizing this system have demonstrated considerable boosts to employee productivity, reduced error rates, improved documentation and significant overall cost savings. We believe such systems are the wave of the future and we are excited to be the exclusive distributor across the United States for this exciting technology."
The Mobipen™ application is currently being used by over 50 municipalities in Northern Europe to better document home healthcare visits. Mobipen care is integrated with the D-PAS digital pen and paper technology, based on Anoto Technology.
You can see more about Mobipen at http://www.pashealth.com/D-PAS_Mobipen.html on the www.pashealth.com website.
About Catrel AB
Catrel AB was founded in 2003 and is the number one developing company for IT-system solutions for the digital pen and paper technology within the home and healthcare industry. The Company has developed rapidly and has created great solutions inspired by an evolutionary technology. The system makes it possible to quickly transmit handwritten information from paper directly to digital media. This is done by using a digital pen and paper.
About Patient Access Solutions, Inc.
Patient Access Solutions, Inc. (PAS) is a Healthcare Solutions Company which has created a formidable array of technology, resources and allies to enable it to become an agent of radical change in what has traditionally been a slowly evolving healthcare information technology environment. The Company's products are designed to allow health care providers an easy migration to the EMR environment. Among these products are D-PAS, which is a state-of-the-art digital pen and paper technology based on Anoto technology, used to capture hand written information into digital forms and EMR systems and PAS Data Center, which is a terminal solution that allows health care providers to quickly and easily determine benefit eligibility. More information on Patient Access Solutions, Inc. and its products can be viewed at www.pashealth.com.
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things, the following: general economic and business conditions; competition; unexpected changes in technologies and technological advances; ability to commercialize and manufacture products; results of experimental studies; research and development activities; changes in, or failure to comply with, governmental regulations; and the ability to obtain adequate financing in the future. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of Patient Access Solutions Inc. Securities and Exchange Commission filings available at http://www.sec.gov.